Moreover, recently NRG1 has been demonstrated via the same mechanism of ErbB3-AKT activation, decreased TG levels, and inhibited steatosis in a hepatic cellular model of nonalcoholic fatty liver disease, thus validating a protective role of NRG1 in the pathogenesis of hepatic steatosis [10]. Here, NRG1 is linked to metabolic dysfunction-associated steatotic liver disease.